Use of genetic and genomic markers to predict outcome and improve resource utilization in treatment of chronic hepatitis C infection
Use of genetic and genomic markers to predict outcome and improve resource utilization in treatment of chronic hepatitis C infection
批准号:
209146
负责人:
Feld Jordan J
金额:
$20.4万
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-07-01 至 2012-07-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus (HCV) infection is a major public health problem, infecting 200 million people worldwide, including 1-3% of all Canadians. HCV infection causes slowly progressive liver disease that can lead to liver failure, liver cancer and death.
Al
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
National Hepatitis C Elimination Meeting: Sharing Progress, Re-Igniting Efforts, 2024
-
批准号:480809
-
项目类别:Miscellaneous Programs
-
资助金额:$1.46万
-
财政年份:2023
-
负责人:Feld Jordan J
-
依托单位:
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
-
批准号:478700
-
项目类别:Operating Grants
-
资助金额:$100.04万
-
财政年份:2023
-
负责人:Feld Jordan J
-
依托单位:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
-
批准号:460792
-
项目类别:Miscellaneous Programs
-
资助金额:$1.46万
-
财政年份:2022
-
负责人:Feld Jordan J
-
依托单位:
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
-
批准号:472508
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2022
-
负责人:Feld Jordan J
-
依托单位:
Characterization of very early events in hepatitis C virus infection during transplant from infected donors to uninfected recipients
-
批准号:445421
-
项目类别:Operating Grants
-
资助金额:$54.34万
-
财政年份:2021
-
负责人:Feld Jordan J
-
依托单位:
Peginterferon lambda to treat outpatients with COVID-19 to prevent severe disease: Focus on variants of concern
-
批准号:449005
-
项目类别:Operating Grants
-
资助金额:$72.44万
-
财政年份:2021
-
负责人:Feld Jordan J
-
依托单位:
Third Canadian Symposium on Hepatitis C Virus
-
批准号:289580
-
项目类别:Miscellaneous Programs
-
资助金额:$1.82万
-
财政年份:2013
-
负责人:Feld Jordan J
-
依托单位:
Randomized controlled trial of the efficacy of pre-emptive tenofovir to prevent hepatitis B reactivation in patients who are anti-HBc antibody positive receiving curative intent rituximab-based chemotherapy for non-Hodgkin's lympohma
-
批准号:282389
-
项目类别:Operating Grants
-
资助金额:$10.45万
-
财政年份:2013
-
负责人:Feld Jordan J
-
依托单位:
海外基金